12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Other News

Aveo Pharmaceuticals cancer news

Aveo disclosed in an SEC filing that on July 3 it received a subpoena from the SEC seeking documents related to cancer candidate tivozanib. The company, which said it intends to fully cooperate with the "fact-finding" inquiry, is not providing additional comment.

In June,...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >